Presented by
Management Forum
In this practical, one-day course, learn the regulatory requirements needed for successful post-market surveillance of medical devices and IVDs.
★★★★★ "Overall, I found the webinar to be highly informative and well-organized. The content was comprehens... more"
10 October 2024
+ 12 February 2025, 5 June 2025, 9 October 2025 »
from £549
Understanding the regulatory requirements for successful post-market surveillance of medical devices and IVDs is increasingly important and practical application of the regulations is key to a successful PMS system.
This course will provide a clear understanding of the intention of the requirements, and discuss the responsibilities of the manufacturer, notified bodies and competent authorities. It will also provide advice on where to find useful guidance and will include an insight into some possible PMS methodologies for a range of example medical devices and IVD products, including software.
A review of the reporting and documentation obligations will be included, to enable participants to fully understand and comply with the documentation requirements.
The regulations for PMS under the MDR and IVDR are complex and this course provides an excellent opportunity to gain essential knowledge, practical application and interpretation of the requirements.
This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.
This course will be valuable to those with an existing knowledge of the regulations who are tasked with PMS, but not sure where to start or who have encountered difficulties obtaining PMS data. Personnel in the following roles and departments will benefit:
Karen Pearson has over 30 years’ experience of market research in the healthcare and business-to-business sectors.
Karen started her market research career with IMS, providing market data to the European pharmaceutical sector, before moving on to 3M Health Care, BASF and The Royal Society For The Prevention of Accidents (RoSPA). She started Active Research in 1998 offering a full market research service to pharmaceutical, medical product and business-to-business organisations as well as the public sector.
Active Research focuses on finding practical research solutions that will deliver actionable results for clients, whether that be through, qualitative, quantitative or desk research.
Active Research’s clients include 3M Health Care, Napp Pharmaceuticals, the Cell & Gene Therapy Catapult, Takeda, Kyowa Kirin, Aristo Pharmaceuticals, Lockdown Medical and other leading names in their fields.
Qualifications/Accreditations:
BA (Hons) Modern Languages
DipCIM
MMRS (Full membership of the Market Research Society)
Anne Jury is a regulatory affairs consultant with over 25 years experience in the medical and diagnostic healthcare products industries. With a degree in Microbiology, she went to work as company microbiologist for Smith & Nephew Textiles on sterile wound dressing products. Later she went on to work for Notified Bodies, BSI and then TÜV Product Service as a lead auditor covering over 200 medical companies in Europe and USA.
Anne is a member of TOPRA, (The Organisation for Professionals in Regulatory Affairs) and RAPS, (Regulatory Affairs Professionals Society) and a regular speaker at conferences world-wide. Through close association with like minded organizations such as Medilinks, the DTI and NHS Innovations Hubs as well as biotechnology incubators around the UK, she is active in the promotion of integrated management and regulatory systems to assist the successful introduction of new products to market.
Since March 2020, she is also Vice President of Team-PRRC.
Specialties: Technical guidance on regulatory strategies and quality management systems for new medical device product commercialization, including CE marking requirements, implementation of management systems to ISO 13485:2016 and training / coaching in these areas.
Gap analysis compliance audits for manufacturers and subcontract third party auditor for Notified Bodies.
Past visiting lecturer at Cranfield University (through TOPRA) on MScs in Medical Technology Regulatory Affairs.
Vice-President of Team-PRRC, a non-profit association in EU to support those taking on the PRRC role under MDR and IVDR.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
Please contact us for pricing if you are interested in booking 5 or more delegates
10 October 2024
Live online
09:30-16:30 UK (London) (UTC+01)
10:30-17:30 Paris (UTC+02)
04:30-11:30 New York (UTC-04)
Course code 14328
Not ready to book yet?
for 7 days, no obligation
12 February 2025
Live online
09:30-16:30 UK (London) (UTC+00)
10:30-17:30 Paris (UTC+01)
04:30-11:30 New York (UTC-05)
Course code 14505
Until 08 Jan
Not ready to book yet?
for 7 days, no obligation
5 June 2025
Live online
09:30-16:30 UK (London) (UTC+01)
10:30-17:30 Paris (UTC+02)
04:30-11:30 New York (UTC-04)
Course code 14731
Until 01 May
Not ready to book yet?
for 7 days, no obligation
9 October 2025
Live online
09:30-16:30 UK (London) (UTC+01)
10:30-17:30 Paris (UTC+02)
04:30-11:30 New York (UTC-04)
Course code 14997
Until 04 Sep
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Overall, I found the webinar to be highly informative and well-organized. The content was comprehensive and relevant, covering key aspects of post-market surveillance for medical devices and IVDs in a clear and understandable manner. The presentation was engaging and well-structured, making complex topics accessible even for beginners like myself. The speakers were knowledgeable and articulate, effectively conveying their expertise and experience. Their willingness to engage with participants and answer questions added significant value to the session. Overall, it was a valuable learning experience that exceeded my expectations.
Jun 6 2024
Ajla Music
Pharmacovigilance Officer, Billev farmacija vzhod d.o.o.
Denmark
Italy
Slovenia
United Kingdom
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: